advertisement
Heegaard S 10
Showing records 1 to 10 | Display all abstracts from Heegaard S106366 Topical eye medications causing allergic contact dermatitis
Ahlström MG
Contact Dermatitis 2023; 88: 294-299
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Sperling S
Acta Ophthalmologica 2023; 101: 384-391
106366 Topical eye medications causing allergic contact dermatitis
Skov L
Contact Dermatitis 2023; 88: 294-299
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Stokholm L; Thykjaer AS
Acta Ophthalmologica 2023; 101: 384-391
106366 Topical eye medications causing allergic contact dermatitis
Heegaard S; Zachariae C
Contact Dermatitis 2023; 88: 294-299
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Pedersen FN
Acta Ophthalmologica 2023; 101: 384-391
106366 Topical eye medications causing allergic contact dermatitis
Garvey LH
Contact Dermatitis 2023; 88: 294-299
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Möller S
Acta Ophthalmologica 2023; 101: 384-391
106366 Topical eye medications causing allergic contact dermatitis
Johansen JD
Contact Dermatitis 2023; 88: 294-299
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Laugesen CS; Andersen N; Andresen J; Bek T; la Cour M; Hajari J; Heegaard S; Højlund K; Kawasaki R; Kolko M; Schielke KC; Rubin KH; Vestergaard AH; Grauslund J
Acta Ophthalmologica 2023; 101: 384-391
